annual total liabilities:
$1.13B+$109.60M(+10.75%)Summary
- As of today (May 29, 2025), NBIX annual total liabilities is $1.13 billion, with the most recent change of +$109.60 million (+10.75%) on December 31, 2024.
- During the last 3 years, NBIX annual total liabilities has risen by +$430.50 million (+61.63%).
- NBIX annual total liabilities is now at all-time high.
Performance
NBIX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$1.15B+$23.00M(+2.04%)Summary
- As of today (May 29, 2025), NBIX quarterly total liabilities is $1.15 billion, with the most recent change of +$23.00 million (+2.04%) on March 31, 2025.
- Over the past year, NBIX quarterly total liabilities has increased by +$65.70 million (+6.05%).
- NBIX quarterly total liabilities is now at all-time high.
Performance
NBIX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NBIX Total liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +10.8% | +6.0% |
3 y3 years | +61.6% | +52.9% |
5 y5 years | +68.7% | +74.1% |
NBIX Total liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +70.8% | at high | +97.8% |
5 y | 5-year | at high | +85.5% | at high | +97.8% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
NBIX Total liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $1.15B(+2.0%) |
Dec 2024 | $1.13B(+10.8%) | $1.13B(+38.3%) |
Sep 2024 | - | $816.10M(+2.6%) |
Jun 2024 | - | $795.80M(-26.7%) |
Mar 2024 | - | $1.09B(+6.6%) |
Dec 2023 | $1.02B(+54.2%) | $1.02B(+20.5%) |
Sep 2023 | - | $846.10M(+11.3%) |
Jun 2023 | - | $760.10M(+12.6%) |
Mar 2023 | - | $675.30M(+2.2%) |
Dec 2022 | $660.90M(-5.4%) | $660.90M(+10.4%) |
Sep 2022 | - | $598.80M(+2.8%) |
Jun 2022 | - | $582.30M(-22.7%) |
Mar 2022 | - | $753.40M(+7.9%) |
Dec 2021 | $698.50M(+14.8%) | $698.50M(+4.1%) |
Sep 2021 | - | $671.30M(-0.9%) |
Jun 2021 | - | $677.20M(+5.7%) |
Mar 2021 | - | $640.80M(+5.3%) |
Dec 2020 | $608.50M(-9.1%) | $608.50M(-12.9%) |
Sep 2020 | - | $698.30M(+2.0%) |
Jun 2020 | - | $684.40M(+3.4%) |
Mar 2020 | - | $661.60M(-1.1%) |
Dec 2019 | $669.10M(+30.6%) | $669.10M(+10.5%) |
Sep 2019 | - | $605.42M(+3.8%) |
Jun 2019 | - | $583.15M(+6.3%) |
Mar 2019 | - | $548.45M(+7.0%) |
Dec 2018 | $512.39M(+15.0%) | $512.39M(+5.4%) |
Sep 2018 | - | $486.23M(+4.8%) |
Jun 2018 | - | $463.88M(+5.0%) |
Mar 2018 | - | $441.87M(-0.8%) |
Dec 2017 | $445.45M(+787.2%) | $445.45M(+4.8%) |
Sep 2017 | - | $424.98M(+3.9%) |
Jun 2017 | - | $408.85M(+868.3%) |
Mar 2017 | - | $42.22M(-15.9%) |
Dec 2016 | $50.21M(-0.2%) | $50.21M(+5.7%) |
Sep 2016 | - | $47.51M(-2.6%) |
Jun 2016 | - | $48.80M(+5.2%) |
Mar 2016 | - | $46.37M(-7.9%) |
Dec 2015 | $50.33M(+46.6%) | $50.33M(+10.6%) |
Sep 2015 | - | $45.49M(+2.8%) |
Jun 2015 | - | $44.27M(+2.8%) |
Mar 2015 | - | $43.05M(+25.4%) |
Dec 2014 | $34.33M(+0.2%) | $34.33M(+1.8%) |
Sep 2014 | - | $33.71M(+3.1%) |
Jun 2014 | - | $32.69M(+1.4%) |
Mar 2014 | - | $32.24M(-5.9%) |
Dec 2013 | $34.27M(-17.6%) | $34.27M(-6.6%) |
Sep 2013 | - | $36.67M(-5.5%) |
Jun 2013 | - | $38.80M(-0.4%) |
Mar 2013 | - | $38.97M(-6.3%) |
Dec 2012 | $41.61M(-46.9%) | $41.61M(-16.7%) |
Sep 2012 | - | $49.95M(-12.9%) |
Jun 2012 | - | $57.35M(-13.5%) |
Mar 2012 | - | $66.31M(-15.3%) |
Dec 2011 | $78.29M(-37.4%) | $78.29M(-14.2%) |
Sep 2011 | - | $91.28M(-10.4%) |
Jun 2011 | - | $101.85M(-8.2%) |
Mar 2011 | - | $111.00M(-11.3%) |
Dec 2010 | $125.08M | $125.08M(-6.2%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | $133.29M(-6.6%) |
Jun 2010 | - | $142.63M(+125.8%) |
Mar 2010 | - | $63.16M(-5.5%) |
Dec 2009 | $66.86M(-17.9%) | $66.86M(-10.6%) |
Sep 2009 | - | $74.83M(-5.9%) |
Jun 2009 | - | $79.52M(-2.9%) |
Mar 2009 | - | $81.92M(+0.6%) |
Dec 2008 | $81.41M(-48.5%) | $81.41M(-43.5%) |
Sep 2008 | - | $144.09M(-1.2%) |
Jun 2008 | - | $145.83M(+0.4%) |
Mar 2008 | - | $145.22M(-8.1%) |
Dec 2007 | $157.96M(+110.7%) | $157.96M(+117.7%) |
Sep 2007 | - | $72.54M(-0.4%) |
Jun 2007 | - | $72.81M(+1.1%) |
Mar 2007 | - | $72.01M(-3.9%) |
Dec 2006 | $74.96M(-19.4%) | $74.96M(-3.5%) |
Sep 2006 | - | $77.66M(-3.9%) |
Jun 2006 | - | $80.77M(-13.7%) |
Mar 2006 | - | $93.57M(+0.6%) |
Dec 2005 | $93.02M(-25.8%) | $93.02M(-4.3%) |
Sep 2005 | - | $97.23M(-6.1%) |
Jun 2005 | - | $103.49M(-7.3%) |
Mar 2005 | - | $111.65M(-11.0%) |
Dec 2004 | $125.39M(-23.5%) | $125.39M(-10.5%) |
Sep 2004 | - | $140.06M(+3.8%) |
Jun 2004 | - | $134.94M(-11.1%) |
Mar 2004 | - | $151.86M(-7.3%) |
Dec 2003 | $163.84M(+287.5%) | $163.84M(-1.0%) |
Sep 2003 | - | $165.57M(+1.7%) |
Jun 2003 | - | $162.79M(+10.1%) |
Mar 2003 | - | $147.83M(+249.6%) |
Dec 2002 | $42.28M(+17.6%) | $42.28M(+8.9%) |
Sep 2002 | - | $38.81M(+13.7%) |
Jun 2002 | - | $34.14M(-0.6%) |
Mar 2002 | - | $34.35M(-4.5%) |
Dec 2001 | $35.96M(+58.0%) | $35.96M(+10.9%) |
Sep 2001 | - | $32.42M(+56.2%) |
Jun 2001 | - | $20.76M(+6.2%) |
Mar 2001 | - | $19.55M(-14.1%) |
Dec 2000 | $22.75M(+77.8%) | $22.75M(+53.5%) |
Sep 2000 | - | $14.82M(+34.1%) |
Jun 2000 | - | $11.05M(-23.0%) |
Mar 2000 | - | $14.36M(+12.2%) |
Dec 1999 | $12.80M(+50.6%) | $12.80M(+42.2%) |
Sep 1999 | - | $9.00M(+23.3%) |
Jun 1999 | - | $7.30M(+10.6%) |
Mar 1999 | - | $6.60M(-22.4%) |
Dec 1998 | $8.50M(-2.3%) | $8.50M(+3.7%) |
Sep 1998 | - | $8.20M(+60.8%) |
Jun 1998 | - | $5.10M(-16.4%) |
Mar 1998 | - | $6.10M(-29.9%) |
Dec 1997 | $8.70M(+67.3%) | $8.70M(+35.9%) |
Sep 1997 | - | $6.40M(-3.0%) |
Jun 1997 | - | $6.60M(+15.8%) |
Mar 1997 | - | $5.70M(+9.6%) |
Dec 1996 | $5.20M | $5.20M(+30.0%) |
Sep 1996 | - | $4.00M(-18.4%) |
Jun 1996 | - | $4.90M(+25.6%) |
Mar 1996 | - | $3.90M |
FAQ
- What is Neurocrine Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual total liabilities year-on-year change?
- What is Neurocrine Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly total liabilities year-on-year change?
What is Neurocrine Biosciences annual total liabilities?
The current annual total liabilities of NBIX is $1.13B
What is the all time high annual total liabilities for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual total liabilities is $1.13B
What is Neurocrine Biosciences annual total liabilities year-on-year change?
Over the past year, NBIX annual total liabilities has changed by +$109.60M (+10.75%)
What is Neurocrine Biosciences quarterly total liabilities?
The current quarterly total liabilities of NBIX is $1.15B
What is the all time high quarterly total liabilities for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly total liabilities is $1.15B
What is Neurocrine Biosciences quarterly total liabilities year-on-year change?
Over the past year, NBIX quarterly total liabilities has changed by +$65.70M (+6.05%)